摘要
目的观察康莱特联合沙培林腹腔灌注治疗胰腺癌所致恶性腹水的临床疗效。方法将50例患者随机分为治疗组与对照组各25例,均予康莱特200ml静滴,每日1次;治疗组予沙培林10KE加生理盐水20ml、对照组予顺铂80mg加生理盐水40ml腹腔灌注,均每周1次。疗程均为3周。结果治疗组总有效率80%,与对照组比较无显著性差异,但生存质量改善显著优于对照组。结论康莱特联合沙培林腹腔灌注治疗胰腺癌所致恶性腹水疗效较佳,并且能显著提高患者生存质量。
Objective：To evaluate the therapeutic effects of Kanglaite combined with Sapylin infusing peritoneal in treatment of malignant peritoneal effusion in patients with Pancreatic cancer. Methods： Fifty patients were divided into two groups at random： Sapylin 10KE ＋ NS20ml was infused intraperitoneally through a catheter in treatment group （25 cases） and c isplatin（DDP） 80mg ＋ NS40ml was infused i ntraperitoneally through a catheter in control group（25 cases）, Kanglaite was intravenously driped for three weeks in both groups. Results： The overall response rate was 80% in treatment group, but was not statistically significance. The survival quality had statistically significance. Conclusion： Kanglaite combined with Sapylin infusing peritoneal in treatment of malignant peritoneal effusion in patients with Pancreatic cancer have definite efficacy. The survival quality has obviously been improved.
出处
《中国中医急症》
2007年第7期804-805,共2页
Journal of Emergency in Traditional Chinese Medicine
关键词
胰腺癌
恶性腹水
康莱特
沙培林
腹腔灌注
Pancreatic cancer
Infusing peritoneal
Kanglaite
Sapylin
Malignant peritoneal effusion
